Dr. Indra Cidambi discusses technology addiction, its symptoms, effects to health, & family relationships.
Author: healthprofessionalradio
Treating schizophrenia, & its antipsychotic drugs side effects.
Returning guest Dr. Andrew J. Cutler discusses the scientific basis for the host of side effects that can accompany current antipsychotics for treating schizophrenia.
Improve elders’ balance by using flexible brace & ankle & foot orthotics
Dr. Jonathan Moore discusses a recent study by The Journal of Gerontology that revealed that a flexible brace (Moore Balance Brace) used on a daily basis and ankle and foot orthotics “profoundly improved senior citizens’ balance by 55% and significantly reduced their fear of falling and increased their level of activity”.
Drug delivery training devices that help patients learn to administer their injection medications
Joe Reynolds leverages the knowledge of the pharmaceutical and medical device industries to derive insights and maximize value for all members of the Noble healthcare team. His experience includes work with various consumer and healthcare brands. Joe holds a Bachelor of Science in Business from the University of Central Florida, a Master’s of Science in Marketing from the University of South Florida and a Master’s of Science in Pharmacy from the University of Florida.
Solving common issues faced by pediatric patients through augmented reality app
Hernâni Oliveira Ph.D., a molecular oncologist, health communicator, digital media researcher, and grand prize winner of the Astellas 2017 C3 (Changing Cancer Care) Grand Prize discusses an augmented reality app to help solve common issues faced by pediatric patients and their parents around education and physical engagement.
Elder Law and the Different Needs of Seniors
Yale S. Hauptman, Esq, founding partner, Hauptman & Hauptman, PC, and Laurie A. Hauptman, Partner, Hauptman & Hauptman, PC., discuss elder law as it applies to medical special needs, long term care, financial issues, government benefits, and more.
Nonalcoholic Fatty Liver Disease (NAFLD)
Donna R. Cryer, JD, CEO of the Global Liver Institute and Wayne Eskridge, Founder, and CEO of the Fatty Liver Foundation, discuss nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)
Matrix New World Engineering
Dr. Laurie LaPat-Polasko, Microbiologist and Vice President/National Director of Remediation for Matrix New World Engineering, discusses contaminants that affect our planet, clean water supply, and how it affects our health.
Spot On Sciences – Dried Blood Spot Sample Collection
Nima Nejad Shiraz, VP of Finance & Operations at Tribeca Companies and COO with Spot-On Sciences, discusses the next generation of Dried Blood Spot (DBS) sample collection, and their partnering with Tribeca Companies to conduct an expansion of the company’s activities into new global markets.
Phase 3 Study of Recurrent Metastatic HNSCC with KEYTRUDA
As of June 11, 2019, Merck’s KEYTRUDA is now FDA approved for first-line treatment of patients with metastatic or with unresectable, recurrent head and neck squamous cell carcinoma as monotherapy for patients whose tumors express PD-L1 (CPS ≥1) or in combination with platinum and fluorouracil (FU) regardless of PD-L1 expression. Returning guest Dr. Danny Rischin, Director of the Department of Medical Oncology, Peter MacCallum Cancer Centre (Melbourne, Australia) discusses the final analysis of the Phase 3 KEYNOTE-048, KEYTRUDA study, which was presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.